New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2013
05:19 EDTGWPHGW Pharmaceuticals files new regulatory application to expand Sativex in France
GW Pharmaceuticals announced that it has submitted an application under the European Mutual Recognition Procedure, or MRP, seeking to expand the marketing authorization for Sativex into France for the treatment of spasticity due to Multiple Sclerosis. This new regulatory application follows a Decree signed by the French Minister of Health in June, which amended national legislation in France so as to permit a prescription cannabis-based medicine, subject to approval by ANSM, the French regulatory authority.
News For GWPH From The Last 14 Days
Check below for free stories on GWPH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 8, 2014
09:00 EDTGWPHGW Pharmaceuticals falls 2.3%
GW Pharmaceuticals is down 2.3%, or $1.18, to $50.16

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use